Skip to main content
. 2018 Apr 26;8:6586. doi: 10.1038/s41598-018-24633-3

Figure 1.

Figure 1

Expression of Elovl6 in human hepatocellular carcinoma. (a) RNA transcripts of Elovl6 expression in thirty hepatocellular carcinomas. (b) Immunostaining intensity of clinical samples with low or high expression of Elovl6. (c) The correlation of expression of Elovl6 and differentiation in HCC samples. Disease-free (d) and overall (e) survival in HCC patients with high or low expression of Elovl6. Statistical differences were analyzed using the log-rank test.